Understanding MDCG 2021-24 Rev Guidance for Accurate Medical Device Classification
- Aug 11
- 4 min read
Medical device classification plays a crucial role in ensuring patient safety and regulatory compliance. The MDCG 2021-24 revision offers updated guidance to help manufacturers and stakeholders correctly classify medical devices under the European Medical Device Regulation (MDR). This blog post breaks down the key points of the MDCG 2021-24 rev guidance, explains its practical implications, and provides clear examples to help you apply it effectively.
Why Accurate Medical Device Classification Matters
Classifying a medical device correctly determines the regulatory path it must follow. This affects:
The level of scrutiny during conformity assessment
The type of clinical evidence required
Post-market surveillance obligations
The overall time and cost to bring the device to market
Misclassification can lead to delays, increased costs, or even legal consequences. The MDCG 2021-24 rev guidance aims to clarify classification rules and reduce ambiguity.
Overview of MDCG 2021-24 Revision
The MDCG 2021-24 revision updates the previous guidance by:
Clarifying ambiguous classification rules
Providing examples for borderline cases
Addressing new device technologies and software
Aligning classification with MDR Annex VIII rules
This guidance helps manufacturers interpret the MDR classification rules more consistently and supports notified bodies in their assessments.
Key Principles of Medical Device Classification Under MDR
The MDR classifies devices into four classes based on risk:
Class I (low risk)
Class IIa (medium risk)
Class IIb (medium-high risk)
Class III (high risk)
Classification depends on:
Intended purpose of the device
Duration of contact with the body
Degree of invasiveness
Whether the device is active or implantable
The MDCG 2021-24 rev guidance emphasizes that the intended purpose declared by the manufacturer is the starting point for classification.
How to Use the MDCG 2021-24 Guidance Effectively
Step 1: Define the Intended Purpose Clearly
The guidance stresses the importance of a precise intended purpose statement. This includes:
Target patient population
Clinical condition addressed
Mode of action
Duration and site of use
For example, a device intended to monitor blood glucose continuously will be classified differently than one used for occasional spot checks.
Step 2: Apply Classification Rules Systematically
The guidance walks through MDR Annex VIII rules with detailed explanations. Some examples:
Rule 10 covers active devices intended for diagnosis or monitoring
Rule 11 applies to active therapeutic devices
Rule 14 addresses implantable devices
The document provides flowcharts and decision trees to help navigate these rules.
Step 3: Consider Software and New Technologies
Software as a Medical Device (SaMD) is explicitly addressed. The guidance clarifies:
When software is classified as a medical device
How to classify software based on its function and risk
Examples such as software for image analysis or therapy planning
This helps manufacturers avoid confusion about software classification.
Step 4: Use Examples for Borderline Cases
The guidance includes practical examples, such as:
Devices combining diagnostic and therapeutic functions
Devices with multiple intended purposes
Devices with accessories and their classification impact
These examples help resolve common classification dilemmas.
Practical Examples of Classification Using MDCG 2021-24
Example 1: Wearable Heart Rate Monitor
Intended purpose: Continuous monitoring of heart rate for fitness and health tracking
Classification: Class IIa (active device for monitoring vital physiological parameters)
Reasoning: The device is active, non-invasive, and intended for continuous monitoring, fitting Rule 10.
Example 2: Implantable Cardiac Pacemaker
Intended purpose: Regulate heart rhythm in patients with arrhythmia
Classification: Class III (implantable active therapeutic device)
Reasoning: Implantable device with critical therapeutic function, covered by Rule 8.
Example 3: Software for Diagnostic Image Analysis
Intended purpose: Analyze medical images to assist diagnosis of tumors
Classification: Class IIa or IIb depending on risk and impact on clinical decisions
Reasoning: Software that influences diagnosis is classified based on risk; MDCG 2021-24 provides criteria to determine exact class.
Common Challenges and How MDCG 2021-24 Helps
Ambiguous Intended Purpose
Manufacturers sometimes provide vague descriptions. The guidance encourages detailed, specific intended purposes to avoid misclassification.
Combination Devices
Devices with multiple functions can be tricky. The guidance advises classifying based on the highest risk function.
Software Updates
Software changes can affect classification. The guidance recommends reassessing classification with each significant update.
Tips for Manufacturers to Ensure Compliance
Review the MDCG 2021-24 guidance early in product development
Document the intended purpose with clear clinical context
Use the provided flowcharts and examples to verify classification
Consult with notified bodies if uncertain about borderline cases
Keep classification documentation updated with product changes
The Role of Notified Bodies and Regulators
Notified bodies use the MDCG 2021-24 guidance to assess classification claims. Consistent application helps:
Reduce review times
Avoid rework due to misclassification
Ensure patient safety through appropriate oversight
Manufacturers should maintain open communication with notified bodies during classification discussions.
Summary
The MDCG 2021-24 rev guidance provides clear, practical advice to classify medical devices accurately under the MDR. By focusing on a detailed intended purpose, applying classification rules carefully, and considering software and combination devices, manufacturers can navigate regulatory requirements more confidently. Using this guidance reduces risks of delays and non-compliance, ultimately supporting safer medical devices on the market.
Comments